QuidelOrtho
QDEL
#3543
Rank
โ‚ฌ2.90 B
Marketcap
43,26ย โ‚ฌ
Share price
4.21%
Change (1 day)
-35.46%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

QuidelOrtho (QDEL) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ3.48 Billion

According to QuidelOrtho's latest financial reports the company's total liabilities are โ‚ฌ3.48 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

QuidelOrtho - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ3.21 B-11.97%
2022-12-31โ‚ฌ3.65 B726.33%
2021-12-31โ‚ฌ0.44 B1.05%
2020-12-31โ‚ฌ0.43 B39.7%
2019-12-31โ‚ฌ0.31 B-5.85%
2018-12-31โ‚ฌ0.33 B-43.6%
2017-12-31โ‚ฌ0.59 B230.88%
2016-12-31โ‚ฌ0.17 B3.83%
2015-12-31โ‚ฌ0.17 B3.22%
2014-12-31โ‚ฌ0.16 B381.76%
2013-12-31โ‚ฌ34.54 M7.98%
2012-12-31โ‚ฌ31.99 M-55.57%
2011-12-31โ‚ฌ72 M-6.17%
2010-12-31โ‚ฌ76.73 M175.58%
2009-12-31โ‚ฌ27.84 M65.15%
2008-12-31โ‚ฌ16.86 M-5.8%
2007-12-31โ‚ฌ17.89 M-0.65%
2006-12-31โ‚ฌ18.01 M-19.78%
2005-12-31โ‚ฌ22.45 M35.37%
2004-12-31โ‚ฌ16.59 M-23.96%
2003-12-31โ‚ฌ21.81 M14.97%
2002-12-31โ‚ฌ18.97 M-23.77%
2001-12-31โ‚ฌ24.89 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ91.68 M-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.29 B 768.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ49.45 B 1,318.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ37.16 M-98.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ28.27 B 710.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.37 B 82.72%๐Ÿ‡บ๐Ÿ‡ธ USA